Abstract
This report analyzes the worldwide markets for Human Vaccines in Millions of
US$. The major product segments analyzed are Prophylactic Vaccines (Pediatric
Prophylactic Vaccines, & Adult Prophylactic Vaccines), and Therapeutic
Vaccines. The report provides separate comprehensive analytics for the US,
Canada, Japan, Europe, Asia-Pacific, Middle East and Latin America. Annual
forecasts are provided for each region for the period of 2001 through 2015. A
ten-year historic analysis is also provided for these markets with annual
market analytics. The report profiles 164 companies including many key and
niche players worldwide such as ALK - Abelló A/S, Acambis PLC, Bavarian
Nordic A/S, Crucell N.V., CSL Ltd., GlaxoSmithKline PLC, GlaxoSmithKline
Biologicals S.A, Medimmune, Inc, Merck & Company, Inc., Novartis Vaccines &
Diagnostics, Inc., Sanofi-Aventis S A, Sanofi-Pasteur SA, Sanofi Pasteur,
Inc., Shanta Biotechnics Ltd., Vaxin, Inc., and Wyeth. Market data and
analytics are derived from primary and secondary research. Company profiles
are mostly extracted from URL research and reported select online sources.
| 
View Cart
